Share Name Share Symbol Market Type Share ISIN Share Description
Bioventix LSE:BVXP London Ordinary Share GB00B4QVDF07 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +25.00p +1.03% 2,462.50p 2,425.00p 2,500.00p 2,462.50p 2,450.00p 2,450.00p 922 09:33:59
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 7.2 5.8 96.4 25.6 125.55

Bioventix Share Discussion Threads

Showing 726 to 750 of 750 messages
Chat Pages: 30  29  28  27  26  25  24  23  22  21  20  19  Older
DateSubjectAuthorDiscuss
12/12/2017
09:08
Also some recent research on beta-amyloid which included Tormod Fladby as a contributor in the Psychiatry journal of the American Medical Association. Https://www.ncbi.nlm.nih.gov/pubmed/29188296 Results: "In persons with normal cognition, the age-related increase in low memory score paralleled the age-related increase in amyloid positivity with an intervening period of 10 to 15 years." Not entirely sure how to interpret the results but seems generally supportive of the theory that beta-amyloid increases pre-date cognitive decline by 10+ years.
gsbmba99
12/12/2017
08:53
Some recent research by the wider team in Norway published on Secretoneurin in the November issue of Circulation, a journal of the American Heart Association. Http://circ.ahajournals.org/content/136/Suppl_1/A14626 and Http://circ.ahajournals.org/content/136/Suppl_1/A13900 . The first conclusion says: "SN [secretoneurin] levels provide prognostic information in patients with ACS [acute coronary syndrome], but not in patients hospitalized with non-cardiac chest pain." The second conclusion says: "Production of SN [secretoneurin] may be an endogenous protective mechanism in patients with pathological cardiomyocyte Ca2+ handling, supporting its role as an emerging biomarker."
gsbmba99
08/12/2017
20:47
Not going but would be grateful to hear from anyone who is.
tadders2
08/12/2017
20:19
Anyone going to the AGM? The share price seems to be reflecting the lack of news for a wee while now and has been on a downward trend of late. (guess whose stop loss kicked in today)
soundsplausible
06/12/2017
06:42
Https://www.prnewswire.com/news-releases/roche-supports-fda-communication-about-potential-for-biotin-interference-with-lab-tests-300565232.html Roche has issued guidance on the interaction of Biotin (Vit B7) and streptavidin based assays (including hs-troponin). Dosages of 1mg (as contained in general multi-vitamins) pose no risk of test result interference. With dosages of >5mg, 8hr wait time between taking Biotin and blood draw is recommended. I think this is the study ( Https://www.future-science.com/doi/10.4155/ipk-2017-0013 ) which was conducted in Sep-Oct 16 and recently published. I wonder if the FDA had pre-warned manufacturers they were going to have to study this issue last year?
gsbmba99
06/12/2017
06:31
Http://www.captodayonline.com/next-gen-troponin-gate-labs/ Useful article discussing process for introducing the Roche hs-troponin test at a selection of US hospitals. Early returns, as described in article, appear to be pretty good.
gsbmba99
04/12/2017
09:51
Bioventix isn't presenting in Oslo. It's only Pre-Diagnostics and CardiNor.
gsbmba99
04/12/2017
09:20
14 December 2017 scheduled AGM at the Farnham Castle & 2.30 PM. Clash of dates?!
a1samu
30/11/2017
11:26
Here Leon Boros compares the accounts of YouGov and BVXP, to illustrate why BVXP accounts provide such an attractive investment proposition. hxxp://www.piworld.co.uk/2017/11/30/leon-boros-understanding-accounts-interviewed-by-tamzin-freeman/ This is an educational video about accounting. No other detail about BVXP.
tomps2
30/11/2017
10:51
Https://www.fda.gov/downloads/MedicalDevices/NewsEvents/WorkshopsConferences/UCM586774.pdf The US FDA held a troponin assay workshop on 28 Nov. Flipping through the slides, it would appear the FDA has a number of concerns. Slide 17 says that assays have poor clinical performance. Slide 26 suggests that test results are very different if the blood is stored at room temp for a period of time before testing. Slide 29 says test results are dependent on what type of test tube is used. Slides 40-41 says that lots of Americans take Biotin (Vit B7) and that high levels of Biotin can interfere with test results. There was a death reported to the FDA of a person taking high Biotin doses who received a false negative test result. I wasn't able to find any news or blog commentary on "takeaways" from the session and how resolvable some of the FDA issues are. None of the concerns are attributed to any particular company's test. It would appear that, at a minimum, more clinical data is likely to be needed to alleviate some of the concerns. This might explain why the Abbott device (which articles from Jan suggested had already been submitted) remains uncleared 11 months later (Roche received clearance in 3 months).
gsbmba99
21/11/2017
08:07
New research from University of Birmingham ( Https://www.birmingham.ac.uk/news/latest/2017/11/vitamin-D-arthritis-inflammation-research.aspx ) published in Journal of Autoimmunity. Maintaining sufficient vitamin D levels may help to prevent the onset of inflammatory diseases like rheumatoid arthritis.
gsbmba99
17/11/2017
08:50
Must have been Mr Boros's article I read too from TMF? That was the price I got in too. A wonderful company.
igbertsponk
16/11/2017
23:53
Thanks Trident5
boros10
16/11/2017
19:03
Stepone, Not as late as mine with Hargreaves Lansdown...I’m still waiting! :(
chippyfriday
16/11/2017
10:23
Just noticed that the attendees for that Shares Magazine event I posted about are last year's attendees. So Bioventix may or may not be presenting. One to watch, I guess.
gsbmba99
16/11/2017
09:53
Just wondering as mine with iDealing only turned up this morning. Must have got lost in the post somewhere!
stepone68
16/11/2017
09:45
Could be right about dividends being reinvested. But the trades are for round amounts.
valustar1
16/11/2017
09:43
I don't think so mine were reinvested yesterday by a J bell
lancasterbomber
16/11/2017
09:40
Dividends getting re-invested?
stepone68
16/11/2017
09:34
Hydrus. Well thanks! ShareSoc is an excellent organisation with some great people who give their time for free. Its new leadership have made many improvements. On a personal level I appreciate the kind words.
boros10
16/11/2017
07:47
Bioventix again scheduled to attend Shares Magazine Growth & Innovation Forum ( Https://www.sharesmagazine.co.uk/events/event/growth-innovation-forum-2018 ) on 30 Jan 18.
gsbmba99
16/11/2017
07:47
Bioventix again scheduled to attend Shares Magazine Growth & Innovation Forum ( Https://www.sharesmagazine.co.uk/events/event/growth-innovation-forum-2018 ) on 30 Jan 18.
gsbmba99
10/11/2017
06:57
Leon Boros comes across well. Maybe Sharesoc isn't all bad ;)Thanks for posting
hydrus
10/11/2017
06:54
caution about the troponin transition With Currency hedging would have missed forecasts last year Wouldnt want to be hoilding when this warns it would drop £8 or so horrible head and shioulder pattern on chart would complete with this sharp move down just saying
larva
10/11/2017
01:34
You mean Leon who posts here from time-to-time I take it basem1? Http://www.piworld.co.uk/2017/11/08/leon-boros-on-achieving-exceptional-investment-returns/
lauders
Chat Pages: 30  29  28  27  26  25  24  23  22  21  20  19  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20171214 05:59:36